ALDOA is in low concentrations in post-MI patients’ plasma wherein an increased expression may have a protective role to alleviate oxidative stress and impair cardiomyocyte apoptosis in ischaemic conditions via the VEGF-NOTC1-JAG1 pathway (Luo et al, 2021). Here, ALDOA is linked to myocardial infarction.